Page 7 - ANTIFUNGAL SUSCEPTIBILITY OF CLINICAL YEAST ISOLATES 2018-2020

Susceptibility of Candida parapsilosis complex to echinocandins is 36.6%

for anidulafungin, 91.7% for micafungin, and 58.3% for caspofungin, 83% is
susceptible to fluconazole and 90% to voriconazole.

For Candida tropicalis, susceptibility to echinocandins is 98.8% for

anidulafungin, 100% for micafungin, and 40.3% for caspofungin, 77% is
susceptible to fluconazole and 72.9% to voriconazole.

Susceptibility of Candida glabrata complex to echinocandins is 96.6% for

anidulafungin, 97.7% for micafungin, and 54.9% for caspofungin, 94.6% is
susceptible-dose-dependent to fluconazole.

The antifungal susceptibility results for some other emerging yeasts are

also tabulated: Kodamae ohmeri, Pichia kudriavzevii, Clavispora lusitaniae,

Meyerozyma guilliermondii, Candida haemulonii, Rhodotorula mucilaginosa

were given in tables.

7 |